Current
$124B
5-Year Average
$96.1B
All-Time High
$136B
All-Time Low
$614M
Market cap daily chart for Vertex Pharmaceuticals (VRTX)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Vertex Pharmaceuticals (VRTX) from 2017 to 2026
Latest: +5.9%
Market Cap history table for Vertex Pharmaceuticals (VRTX) from 1991 to 2026
| 2026 | $124B | +5.9% | +$6.91B | ||
| 2025 | $117B | +12.6% | +$13.1B | ||
| 2024 | $104B | -2.0% | -$2.14B | ||
| 2023 | $106B | +41.7% | +$31.2B | ||
| 2022 | $74.8B | +31.1% | +$17.7B | ||
| 2021 | $57.1B | -8.3% | -$5.18B | ||
| 2020 | $62.3B | +9.1% | +$5.18B | ||
| 2019 | $57.1B | +32.9% | +$14.1B | ||
| 2018 | $42.9B | +13.2% | +$5B | ||
| 2017 | $37.9B | +110.5% | +$19.9B | ||
| 2016 | $18B | -40.6% | -$12.3B | ||
| 2015 | $30.4B | +8.6% | +$2.41B | ||
| 2014 | $28B | +67.3% | +$11.2B | ||
| 2013 | $16.7B | +88.2% | +$7.83B | ||
| 2012 | $8.88B | +28.1% | +$1.95B | ||
| 2011 | $6.93B | -1.2% | -$85.6M | ||
| 2010 | $7.02B | -5.4% | -$404M | ||
| 2009 | $7.42B | +73.9% | +$3.15B | ||
| 2008 | $4.27B | +42.5% | +$1.27B | ||
| 2007 | $3B | -29.3% | -$1.24B | ||
| 2006 | $4.24B | +71.6% | +$1.77B | ||
| 2005 | $2.47B | +197.3% | +$1.64B | ||
| 2004 | $830M | +4.2% | +$33.5M | ||
| 2003 | $797M | -33.6% | -$404M | ||
| 2002 | $1.2B | -34.4% | -$630M | ||
| 2001 | $1.83B | -62.2% | -$3.01B | ||
| 2000 | $4.84B | +441.8% | +$3.95B | ||
| 1999 | $893M | +18.7% | +$140M | ||
| 1998 | $753M | -6.0% | -$48.1M | ||
| 1997 | $801M | +6.4% | +$48.4M | ||
| 1996 | $752M | +66.4% | +$300M | ||
| 1995 | $452M | +91.8% | +$216M | ||
| 1994 | $236M | +1.9% | +$4.46M | ||
| 1993 | $231M | +95.3% | +$113M | ||
| 1992 | $118M | +9.8% | +$10.6M | ||
| 1991 | $108M | — | — |
- 2026$124B+5.9%
- 2025$117B+12.6%
- 2024$104B-2.0%
- 2023$106B+41.7%
- 2022$74.8B+31.1%
- 2021$57.1B-8.3%
- 2020$62.3B+9.1%
- 2019$57.1B+32.9%
- 2018$42.9B+13.2%
- 2017$37.9B+110.5%
- 2016$18B-40.6%
- 2015$30.4B+8.6%
- 2014$28B+67.3%
- 2013$16.7B+88.2%
- 2012$8.88B+28.1%
- 2011$6.93B-1.2%
- 2010$7.02B-5.4%
- 2009$7.42B+73.9%
- 2008$4.27B+42.5%
- 2007$3B-29.3%
- 2006$4.24B+71.6%
- 2005$2.47B+197.3%
- 2004$830M+4.2%
- 2003$797M-33.6%
- 2002$1.2B-34.4%
- 2001$1.83B-62.2%
- 2000$4.84B+441.8%
- 1999$893M+18.7%
- 1998$753M-6.0%
- 1997$801M+6.4%
- 1996$752M+66.4%
- 1995$452M+91.8%
- 1994$236M+1.9%
- 1993$231M+95.3%
- 1992$118M+9.8%
- 1991$108M—
Market Cap values are taken from Vertex Pharmaceuticals's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported market cap is $114B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2026 fiscal year, Vertex Pharmaceuticals (VRTX) reported market cap of $124B – grew 5.9% year-over-year.
Vertex Pharmaceuticals market cap has grown for 2 consecutive years, with a +16.8% compound annual growth rate over 2021–2026 (5 years).
The highest annual market cap of $124B was reported in 2026. The lowest in the available history was $108M in 1991.
Vertex Pharmaceuticals Market Cap by Year
Vertex Pharmaceuticals Market Cap 2026: $124B
2026's market cap for Vertex Pharmaceuticals came in at $124B, grew 5.9% from 2025. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals Market Cap 2025: $117B
Vertex Pharmaceuticals posted market cap of $117B in 2025, grew 12.6% from 2024.
Vertex Pharmaceuticals Market Cap 2024: $104B
In 2024, Vertex Pharmaceuticals reported market cap of $104B, edged down 2.0% below 2023.
Vertex Pharmaceuticals Market Cap 2023: $106B
Vertex Pharmaceuticals market cap in 2023 was $106B, surged 41.7% from 2022.
Vertex Pharmaceuticals Market Cap 2022: $74.8B
Vertex Pharmaceuticals market cap in 2022 was $74.8B.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers by Market Cap
Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on VRTX
Market Cap — 10 rounds, every one of them VRTX against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Vertex Pharmaceuticals (VRTX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.